SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-095537
Filing Date
2024-08-12
Accepted
2024-08-12 17:15:08
Documents
14
Period of Report
2024-08-12
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K dyn-20240812.htm   iXBRL 8-K 50543
2 EX-99.1 dyn-ex99_1.htm EX-99.1 124840
3 GRAPHIC img259164492_0.jpg GRAPHIC 34220
4 GRAPHIC img259164492_1.jpg GRAPHIC 631
  Complete submission text file 0000950170-24-095537.txt   356135

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dyn-20240812.xsd EX-101.SCH 30687
16 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20240812_htm.xml XML 4697
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 241197919
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)